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Abstract
Bicuspid aortic valve (BAV) is one of the most common congenital diseases, affecting 
1–2% of the general population. Although most of them are sporadic, some familial cases 
have also been detected. BAV is a complex developmental and progressive pathology, 
which may present with various clinical findings from newborn to adulthood. It may be 
suspected during cardiac auscultation or may be diagnosed by echocardiography inci-
dentally. Some BAV cases may remain symptomless for years, with findings like valvular 
stenosis, insufficiency, or dilatation in the ascending aorta, whereas some others may 
present with early severe aortic valve dysfunction, premature congestive heart failure, 
and aortic aneurysms even in the newborn period. Such heterogeneous presentations of 
BAV phenotypes may be associated with congenital, genetic, and/or connective tissue 
abnormalities. The natural course of BAV is nonpredictable, it may lead to severe morbid-
ity and mortality.
Keywords: aortopathy, aortic regurgitation, aortic stenosis, aortic dilatation, aortic 
dissection
1. Introduction
Bicuspid aortic valve (BAV) is one of the most common congenital heart diseases. It is phe-
notypically variable and genetically heterogeneous. The prevalence of the disease has been 
determined according to the results of echocardiographic screening and necropsy studies. 
Some patients with isolated BAV may remain asymptomatic throughout their lives, so they 
may be diagnosed accidentally in echocardiographic screening. Although it is difficult to 
define the real incidence of BAV, it is accepted to have a prevalence of 0.5–2% in the gen-
eral population, with a higher prevalence in males than females: M/F = 3/1 [1, 2]. The clini-
cal presentation of BAV is highly variable. Its major manifestations are aortopathy, valvular 
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 dysfunctions, endocarditis, and dissection. In the patients presenting with valvular dysfunc-
tion earlier in life, aortic regurgitation (AR) is more common, whereas aortic stenosis (AS) is 
more prevalent later in life, after the fourth decade. Valve phenotypes, genetic, and hemody-
namic factors have been proposed as underlying mechanisms of aortopathy. Ascending aortic 
aneurysm is generally due to aortopathy and hemodynamics; however, the aortic root aneu-
rysm is considered to be a consequence of aortopathy rather than hemodynamics, especially 
in younger patients. The asymptomatic BAV patients with normal valvular function require 
surgical treatment less frequently than those with valvular dysfunction and aortopathy dur-
ing their lives.
Moreover, BAV may be associated with several genetic disorders with cardiovascular mani-
festations such as hypoplastic left-heart syndrome, congenital left-sided obstructive lesions 
(coarctation of aorta, Shone complex), ventricular septal defect, and syndromic conditions 
(Turner, Loeys Dietz). This chapter enrolls only the isolated bicuspid aortic valves.
2. Genetic and inheritance
2.1. Associated with genetic syndrome
Although most of the BAV patients are sporadic or familial, some may have the symptoms 
knowngenetic syndromes as Trisomy 18, Williams syndrome, and Turner syndrome. The 
highest penetrance of BAV (>30%) occurs in woman with Turner syndrome caused by par-
tial or complete absence of one X chromosome [3]. In the general population, BAV is more 
prevalent in men than women, suggesting that the loss of genes on the X chromosome may 
predispose to BAV phenotype [3, 4].
2.2. Familial inheritance and genetic etiologies
The heritability of BAV is now well established; however, the genes linked to the defect 
remain largely unknown. Autosomal dominant, X-linked, and familial modes of inheritance 
have been reported. BAV heritage revealed a high incidence of familial clustering. The study 
performed in the Canadian population revealed that 11 of 30 families (36%) had at least 1 
additional member with BAV, and the recurrence rate in first-degree relatives was 9% [5]. 
Another study reported that 100 out of 448 subjects in a Mediterranean population had BAVs, 
348 of which were first-degree relatives. In this study, the BAV recurrence rate in the first-
degree relatives was 4.6%. This value was clearly lower than that in the Canadian population. 
The populations or geographic areas may affect the prevalence of BAVs [6].
Epidemiologic studies have demonstrated that BAV is heritable and follows an autosomal 
dominant mode of transmission with reduced penetrance and variable expressivity [7, 8]. 
Through the linkage analysis of BAV pedigrees, investigators have found multiple genetic 
loci and chromosomes associated with BAV disease [7–16]. The most significantly associated 
genes and the chromosomes they are located on are shown in Table 1. However, some of 
these gene mutations have been found to be related with aortopathies. Several mouse studies 
have showed that the NOTCH1 gene mutation plays an important role in the development of 
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ascending aorta aneurysm and BAV [8, 9, 16]. Although the FBN1 gene mutation frequently 
accompanies Marfan syndrome, its association with BAV and ascending aorta dilatation has 
been shown in a recent study [17]. The pathologic hallmark of aortic aneurysm is medial 
degeneration. Disruption of the smooth muscle cells’ (SMC) contractility due to mutations 
may lead to aortic aneurysm. Mutations in the MYH11 and ACTA2 genes are associated with 
the familial thoracic aortic aneurysms [18].
Consequently, BAV and aortopathy are complex multifactorial and multigenetic pathologies. 
Genetic, epigenetic, and environmental modifiers may be responsible for the variable pen-
etrance and phenotypic expression [4].
3. Aortic root
3.1. Embryology of aortic root
Cardiac and valve morphogenesis occur in early fetal life. Actually the abnormal valvulogen-
esis of BAV has not been clearly understood. Earlier theories proposed that abnormal blood 
flow across the developing valves would result in the failure of cusp separation. Current theo-
ries suggest that cell migration, signaling pathway, and genetic susceptibility are the main 
factors in the development of BAV disease.
The embryonic heart and aorta are developed from three precursor cells: proepicardial cells, 
cardiogenic mesodermal cells (contribute to first and second heart fields [SHfs]), and neu-
ral crest cells. Second heart field (SHF) and the cardiac neural crest (CNC) contribute to the 
Candidate genes Chromosomal regions
TGFBR2 (Transforming growth factor, beta receptor II) 3p24.1
NKX2.5 (NK2 Homeobox 5) 5q35.1
NOTCH1 (Translocation-associated notch protein TAN-1) 9q34.3
ACTA2 (Actin, alpha 2) 10q23.31
MYH6 (Myosin heavy chain 6) 14q11.2
MYH7 (Myosin heavy chain 7, cardiac muscle, beta) 14q11.2
FBN1 (Fibrillin 1) 15q21.1
ENG (Endoglin) 9q34.11
AXIN1 (Axin 1) 16p13.3
KCNJ2 (Potassium channel, inwardly rectifying subfamily J, member 2) 17q24.3
GATA5 (GATA binding protein 5) 20q13.33
PDIA2 (Protein disulfide isomerase family A, member 2) 16p13.3
TGFBR 1 (Transforming growth factor, beta receptor I) 9q22.33
Table 1. Genes with association with bicuspid aortic valve.
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development of aortic root, ascending aorta, and aortic arc. Paraxial mesoderm plays role in 
the development of descending aorta [19, 20]. First heart field (FHF) forms the early embry-
onic heart tube that contributes to the left ventricle and a portion of the right ventricle and 
atria. SHF contributes to the myocardium of the outflow tract to form the truncus arteriosus. 
Mesenchymal cells originating from the migrating cardiac neural crest cells reach the outflow 
tract cushions and contribute to the formation of the aortic and pulmonary valves together 
with the endocardially derived mesenchymal cells. Abnormal migration of neural crest cells 
has been postulated as a common pathway that results in BAV and aortopathy [21–24].
Several proteins are used to determine the positional and functional relationship of various 
cellular populations during embryogenesis. Conical Wnt, non-conical Wnt, TGF-β, fibroblast 
growth factor, bone morphogenetic protein, and Notch are some important proteins in the 
development of aortic valve and aorta. Errors of this pathway may result in various outflow 
tract structural abnormalities including BAV disease [11, 16, 19, 23].
3.2. Histopathology of the aorta
The normal aortic valve involves three layers. The first layer is the inner intimal layer, which 
consists of endothelial cells. The second layer is the thicker medial layer formed of smooth 
muscle cells (SMCs) and elastin. The elastin is arranged in fenestrated sheets (lamellae) 
between which collagen fibers, thin layers of proteoglycan-rich extra-cellular matrix (ECM), 
and SMCs are located. Thin elastic fibers embed lamellae into a three-dimensional network 
and connect them with SMCs. The third layer is the strong adventitial layer with collagen 
fibers wrapping the aorta [25, 26]. The relatively high collagen content of the adventitia pre-
vents vascular rupture at extremely high pressures [27]. SMC and ECM play an important 
role both in the normal tissue development and in the main mechanical function of the aortic 
media [2, 28, 29]. SMCs are the major cell types of the aortic wall that synthesize and organize 
the ECM with the elastic fiber network in the arterial wall [25, 26, 30]. SCMs also provide 
lamellar organization, depending on the diameter and stress applied upon the vessels during 
embryogenesis. ECM, mainly composed of elastin and collagen, is important for the aortic 
strength and flexibility to withstand the arterial blood pressure [26]. The number of lamella is 
greater in larger vessels facing greater wall tension and it seems to remain stable after birth. 
In the normal aorta, SMCs have a little active role in managing wall tension; microfibrillar 
structure is the major passive contributor [26, 30]. As the vessel wall matures, SMCs condense 
down around the endothelial tube to form the circumferential layers, which will finally define 
the elastic lamellae of the mature vessel [30].
3.3. Pathogenesis of aortopathy
Aortopathy is very complex pathology, in which both cellular and extracellular mecha-
nisms are involved. Possible mechanisms for aortopathy in patients with BAV include 
medial degeneration (elastic fiber fragmentation and smooth muscle cell apoptosis), fibri-
lin-1 deficiency, increased metalloproteinase (MMP), and decreased MMP tissue inhibitor 
expression.
Medial degeneration: Failure of the balance between the synthesis and degradation of ECMs 
in the aortic wall leads to aortic aneurysm. Especially elastin is the major fibrillar component 
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in the arterial wall, so its destruction directly leads to the expansion of aorta. Moreover, some 
intrinsic medial degenerative differences have been identified between TAV and BAV patients. 
While degeneration in TAVs has been attributed to inflammation and accelerated aging, it has 
been attributed to the maturation defect in BAVs. Several BAV studies have revealed noninflam-
matory loss of vascular SMCs, less-differentiated vascular SMC, low laminin A/C, and progerin 
expression as the other causes of medial degeneration [27, 30, 31]. The total thickness of the 
aortic media is the same for BAV and TAV aortas, but the distance between the elastic lamel-
lae is greater and the lamellae themselves are thinner and more fragmented in BAV patients 
[30, 32]. It was suggested that matrix disruption and SMC apoptosis were earlier in BAVs with 
stenosis than TAVs with respect to the dilatation of aorta [33]. The patients with ascending 
aorta dilatation with BAV showed lesser cystic medial necrosis (focal loss of vacsular smooth 
muscle cell (VSMC) nuclei in the media) than those with TAV [30]. Nondilated BAV aortas may 
have higher rates of vascular SMC apoptosis, particularly at the convexity, where wall stress 
is expectedly higher. Stress-dependent BAV matrix changes may trigger early apoptosis [33].
Deficiency of fibrilin-1: Maturation defect is maintained in the dilated aortic wall in BAV 
patients. Fibrillin-1, which stabilizes the vascular wall, is secreted by the SMC. It is low in 
BAV patients because of the immaturity of SMC [21]. Deficiency of fibrillin-1 results in vas-
cular SMC detachment, matrix disruption, and apoptosis, which ultimately result in a fragile 
aorta, less suited to deal with stress associated with valvular dysfunction. Decreased levels 
of fibrillin-1 may also lead to tinning and weakening of the aortic wall. Some studies have 
showed that aortic tissues in BAVs have significantly less fibrillin-1 than TAV aortas [34, 35].
Increased activity of MMPs: To date, most studies have focused on MMP-2 and MMP-9, 
which belong to a subclass of MMP. An increase in MMPs, enzymes that process or degrade 
the extracellular matrix, may lead to the weakening of the aortic wall and may be associated 
with the development of aortic aneurysms. In particular, MMP-2 and MMP-9, secreted from 
macrophages, which have infiltrated the inflammatory site, are known as powerful protein-
ases that degrade elastin fiber. BAV patients have dilated aortas with a higher content of 
MMP and a lower level of tissue inhibitor of MMP compared to TAV patients, indicating 
an increased collagen turnover. MMP-9 has been closely associated with the formation of 
abdominal aortic aneurysms [31, 36]. MMP-2 has been identified as a key molecular modula-
tor and a circulation biomarker of aortic dilation in patients with BAV [36]. Several markers 
as c-Kit (a marker for differentiated vascular SMCs), pc-Kit (phosphorylated state of c-Kit, 
triggered by the presence of MMP9), HIF1a (influencing hypoxia-inducible-factor-1alpha), 
and endothelial nitric oxide synthase might play an important role in the pathogenesis of the 
aortopathy [31]. Increased collagen turnover and decreased collagen cross-linking may be 
another factor in the formation of aneurysms in BAV cases [37].
4. Phenotypic presentation of aortic valve and root
4.1. Morphology of bicuspid aortic valve
Normal aortic valve is tricuspid, meaning it possesses three leaflets (or cusps: the left coronary, 
the right coronary, and non-coronary cusps, named after their relationship to the  coronary 
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arteries). However, BAV is formed of two functional leaflets. There are two types of BAV. The 
typical one is the most frequent and is formed of two leaflets of unequal size with complete 
or incomplete fusion of two cusps. Adjacent cusps fuse into a single cusp, that is generally 
bigger than its counterpart cusp, but these fused cusps are smaller than two normal cusps 
combined. In such cases, there may be one or two raphe. The term “raphe” refers to the fused 
area of two underdeveloped cusps turning into malformed commissure between both cusps 
[28, 29]. The second and less commonly encountered type of BAV is “true BAVs,” which have 
leaflets equal in size with no raphe [28]. Morphology of the aortic valve is defined according 
to spatial position of cusps, fusion types, and the number of raphe. The valve morphologies, 
raphe number, and fusion types are shown in Table 2. The fusion positions between the right 
and left coronary cusps (RL BAV), right and non-coronary cusps (RN BAV), and true BAVs are 
shown in Figure 1. The most prevalent aortic valve morphologies are RL BAV phenotypes and 
second, RN BAV phenotypes, and the least common are LN BAV phenotypes [28, 29, 38, 39].
4.2. Aortic phenotype
The aorta is anatomically composed of ascending aorta, aortic arch, thoracic aorta, and 
abdominal aorta. The aortic root contains aortic sinuses, aortic valve, and coronary ostia. The 
tubular portion of the ascending aorta begins at a point distal to the aortic root (sinotubular 
junction) and ends at the origin of the innominate artery. The aortic arch includes the ori-
gins of innominate artery, the left common carotid artery, and the left subclavian artery [40]. 
Figure 2 shows the echocardiographic images and the measurements of aortic root, tubular 
portion of the ascending aorta, and aortic arc. There are computerized tomography images of 
various aortic phenotypes in Figure 3.
Several classifications have been made according to the structure, diameter of aorta, and the 
extent of aortic dilatation. BAV aortopathies generally present with ascending aorta dilata-
tion or root dilatation or both. The types of aortopathies are summarized in Table 3. The 
most common types of aortic dilatation which are seen are the ascending aorta and varying 
degrees of aortic root. This type was associated with an older age at diagnosis (>50 years), 
valvular stenosis, and the RL BAV fusion pattern [29, 40, 41]. Isolated dilatation of the aortic 
root is a rare type and associated with younger age at diagnosis (<40 years), male sex, aortic 
Morphology of aortic valve Type 1 Type 2 Type 3
Raphe present
(Complete or incomplete 
fusion)
Valve opening
Right–left coronary cusps 
fusion
(RL BAV)
Anterior–posterior
Right-non-coronary cusps 
fusion
(RN BAV)
Right–left
Left-non-coronary cusps 
fusion
(LN BAV)
Right–left
Raphe number* 1 raphe 2 raphe
Raphe absent
Valve opening
Anterior–posterior Right–left Right–left
*Type 0: no raphe
Table 2. The bicuspid aortic valve morphologies, fusion types, and raphe number.
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Figure 1. Echocardiographic views of commissural fusion patterns of BAVs and true BAVs. In the first view: Right-left 
coronary cusp fusion a) closed b) opened position; in the second view: Right non coronary cusp fusion a) closed b) 
opened position; in the third view: true BAV anterior-posterior valve position a) closed b) opened position; in the fourth 
view: True BAV right-left position a) closed b) opened position. RCC: right coronary cusp, LCC: left coronary cusp, 
NCC: non coronary cusp, ANT: anterior, POST: posterior.
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regurgitation, and aortopathy. This type was considered most likely to be related with a 
genetic cause [29, 40–42].
4.3. Aortic dilatation
Aortic dimensions are generally measured at the levels of annulus, sinus Valsalva, sinotubu-
lar junction (STJ), ascending aorta, aortic arch, descending aorta, and abdominal aorta, from 
inner edge to inner edge, at the end of diastole in the echocardiographic evaluation. Figure 3  
shows computerized tomography images of aortic root and ascending aorta. Because the 
aorta increases in diameter with somatic growth in children, the aortic diameter is typically 
corrected, mostly for body surface area (BSA), age, and gender. It is important to evaluate chil-
dren under the age of 18 according to the z scores of these measurements. Aorta is accepted to 
have dilatation if the aortic z score is >2, aortic/expected aortic diameter is >1.15, or it is 2 SD 
above the mean expected diameter. Aortic dilation was defined as mild (z score > 2 and ≤ 4), 
moderate (z score > 4 and ≤ 6), or severe/aneurysm (z score > 6 or > 6 SD above the mean for 
BSA) [43]. In adults, aortic dilatation is present if the diameter of sinus Valsalva is >35 mm, 
ascending aorta diameter is >34–38 mm, and an aneurysm is present if the aortic/expected 
diameter is >1.4 or ascending aorta is >45 mm [44–47].
Aortic dilatation may begin early in life and progress with age. It is three times more common 
in BAV patients than in TAVs [48]. In total, 40% of patients in referral centers were reported to 
have BAV-associated aortopathy [49]. BAV patients have significantly larger proximal aorta 
than those with TAV, even in the absence of significant valvular hemodynamic disturbance. 
Children with BAV have larger sinus Valsalva and ascending aorta, which increase in size at 
a higher rate than TAVs [48, 50]. Studies showed that aortic aneurysm also was more common 
Figure 2. Echocardiografic images revealing the measurements of a) aortic root in the long axis view at the annular, sinus 
valsalva, sinotubular junction and ascending aorta levels b) aortic arc at the transverse arc, isthmus and descending aorta 
levels c) sinus valsalva dilatation in long axis view d) ascending aorta dilatation in which aortic root was spared in long 
axis view  e) aortic root and  ascending aorta dilatation in long axis view.
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in BAV than in TAV patients. The most common type of dilatation of aorta in BAVs was the 
ascending aorta dilatation, root dilation was the second, and the least common was the root 
dilatation together with the ascending aorta [44, 48, 51]. Aortic aneurysms in BAVs commonly 
involve aortic root, ascending aorta, and aortic arch [42].
The relationship between the aortic valve structure and dilatation has been investigated in 
several studies. It was reported that RL BAV phenotype was usually associated with aortic 
root and/or sinus Valsalva and/or proximal aortic dilatation [28, 29, 44, 49, 52–55]. RN BAV 
phenotype was more commonly associated with ascending aorta dilatation and LN BAV phe-
notypes with aortic root dilatation [29, 56]. In addition, the RN BAV phenotype was associ-
ated with a more rapid growth of the ascending aorta [43]. On the contrary, a relationship 
between the RL BAV phenotypes and increased risk of rapid aortic dilatation in BAV patients 
has been reported [57]. Clinical variation of the BAV patients may be related to different etio-
logical entities of cusp phenotypes. Recently preclinical studies have shown that RN and RL 
cusps’ fusion have different pathogenesis [58, 59]. In contrast to these studies, only minor dif-
ferences in aortic shape can be demonstrated in different BAV phenotypes. Aortic dilatation 
was primarily caused by intrinsic mechanisms of the aortic wall regardless of valve type [48].
Figure 3. Three dimensional computerized tomography images showing a) ascending aorta dilatation b) sinus valsalva 
and ascending aorta dilatation extended to arcus aorta c) aortic root and ascending aorta dilatation.
Bicuspid Aortic Valve
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4.4. Hemodynamic effect
Flow abnormalities, related to turbulent and helical flow patterns, as a result of the asymmetric 
movement of valve leaflets, may be a major contributor to aortic dilation in BAV. Even nor-
mally functioning BAVs may have abnormal transvalvular flow patterns, resulting in regional 
increases in wall shear stress [60, 61]. The asymmetric opening of even “clinically normal” BAV 
has been demonstrated. The orifice of the open BAV has been shown to be irregular and dome 
shaped due to the restricted motility of conjoined leaflets. This asymmetric and morphologi-
cally stenotic orifice leads to a nonaxial, turbulent transvalvular flow jet, which propagates 
eccentrically toward the wall of ascending aorta [61]. Restricted systolic conjoint cusp motion 
may cause flow deflection even if the BAV is normofunctional on echocardiographic evaluation. 
Systolic flow deflection toward the right, affecting the right anterolateral-ascending wall, has 
been demonstrated by magnetic resonance imaging (MRI) [62]. Abnormal cusp motions of BAV, 
including folding or wrinkling of the valve tissue and increased cusp doming during the car-
diac cycle, may result in altered flow characteristics even when the cusps are not stenotic [63].
MRI studies have shown that RL BAV phenotype is associated with rightward flow devia-
tion (flow jet directed toward the right anterior aortic wall, which is then propagated in a 
right-handed helical direction) and dilatation of tubular portion of the ascending aorta. Right 
anteriorly oriented flow jet may also result in larger aortic root dimensions and asymmetric 
dilatation of midascending tract [53]. However, RN BAV phenotype has been linked to the 
leftward deviation (flow jet directed toward left posterior aortic wall) and diffuse dilatation of 
the ascending aorta extending to the arch [64, 65]. The RN BAV phenotypes have shown more 
severe hemodynamic flow abnormalities than the RL BAV phenotypes [65].
Classification
Shafer et al. [28] Type N (normal root)
Ascending < sinuses 
>STJ
Type A (ascending 
dilatation)
Ascending > sinuses 
>STJ
Type E (effaced roots)
Sinuses < STJ
Fazel et al. [43] Cluster I
Aortic root alone
Cluster II
Tubular ascending aorta 
alone
Cluster III
Tubular portion and 
transverse arch
Cluster IV
Aortic root and 
tubular portion with 
tapering across the 
transverse arc
Verma et al. [41] Type 1
Dilatation of 
tubular ascending 
aorta primarily 
along convexity of 
aorta, with mild-
to-moderate root 
dilatation
Type 2
Arch dilatation with 
involvement of tubular 
ascending aorta, with 
relative sparing of root
Type 3
Isolated aortic-root 
involvement with 
normal tubular 
ascending aorta and 
arch dimensions
STJ: sinotubular junction
Table 3. Aortic dilatation pattern.
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The increase in regional wall shear stress may explain the RL BAV phenotype with dilatation 
of the aortic root and asymmetric dilatation of the tubular ascending aorta. Conversely, a RN 
BAV phenotype may result in a flow toward the posterior aorta, with increased wall shear 
stress at the right posterior aspect of the aorta leading to dilatation of the aortic arch [39].
4.5. Aortic regurgitation and stenosis
BAV disease is strongly associated with different degrees of stenosis, regurgitation, and mixed 
presentations. Although most of the neonates and infants remain asymptomatic, dysfunction may 
present in older ages. Valve interventions may be necessary in a minority, mainly early in life, 
typically for aortic stenosis (AS) [66]. The progression of stenosis is probably similar to that of TAV 
stenosis but it becomes manifested at least 5–10 years earlier in patients with BAV [67]. AS and 
aortic regurgitation (AR) are equally found in TAVs and BAVs with normal aortic dimensions. If 
the aorta is dilated, AS is predominantly associated with BAV, whereas AR is with TAV [48].
Aortic aneurysms associated with AS have been considered to be poststenotic dilatation 
because of the chronic impact of the high-flow velocity turbulent transvalvular jet on the 
aortic wall. Aortic stenosis in BAVs may present a significant additional risk for patients with 
aneurysm [68]. However, not the severity of AS, but the degree of ascending aorta dilation 
and the presence of moderate or more AR is associated with higher aortic root and ascending 
aortic diameter z scores [43]. Moderate–severe AR is generally associated with larger sinus 
Valsalva diameters compared with normally functioning aortic valve and AS. On the other 
hand, moderate–severe AS is associated with a larger ascending aortic diameter compared 
with the normally functioning aortic valve without AR [55]. It is very confusing whether 
the AR causes aortic root dilatation or if the visa versa is true, so careful follow-up of these 
patients is important to understand which presents earlier. The root aneurysm and AR with 
BAV has been linked more often to a genetic/aortopathy cause, which occurs earlier in life, 
independent of hemodynamic factors [44]. In young adults, it has been shown that RN BAV 
pattern is more commonly associated with moderate or severe AS and moderate or more 
AR when compared with other BAV phenotypes. In addition, RN BAV phenotype is associ-
ated with progressive valve dysfunction and is strongly predictive of valve intervention when 
compared with RL BAV phenotype [39, 66]. Similarly, AS has been revealed to be more com-
mon in RN BAV phenotype, whereas AR is most commonly encountered in the patients with 
NL BAV and RL BAV phenotypes [45, 56, 69]. Consequently, despite a variety of study results, 
it can be concluded that RN or RL BAV phenotypes may show progression and AS or AR may 
accompany with both valve morphologies.
5. Diagnosis
Most patients with BAV are unaware of the diagnosis until elderly because the symptoms and 
physical findings are usually absent for many years. Unless echocardiography is requested 
for other indications, the diagnosis is usually made at the time of an adverse cardiovascular 
outcome.
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The systolic ejection murmur of the aortic stenosis, auscultated on the left side of the ster-
num, and the diastolic murmur of the aortic regurgitation, heard mainly on the apex, are 
highly valuable in the diagnosis. In the current area, transthoracic echocardiogram usually 
confirms the diagnosis of BAV disease. For the confirmation, the valve must be visualized 
in systole and diastole in the short axis view. The valve openings are fish-mouth shaped. 
Diastolic images can be misleading because the cusp fusion in the larger leaflet of a bicuspid 
valve may simulate a tri-leaflet valve in the closed position. It may be more difficult to make 
the diagnosis if there is an incomplete fusion between the cusps. The valve closure is usually 
eccentric and the leaflets show doming in the long axis views.
It may be difficult to make the diagnosis in the obese patients due to the nonqualified, blurred 
vision. In such cases, the diagnosis can be established by means of transoesaphagial echocar-
diography (TEE) or cardiac MRI or computerized tomography (CT) imaging.
6. Clinical course
The clinical course of BAV patients is highly non-predictable. The factors determining the 
prognosis are older age, RN or RL BAV phenotype, flow dynamics (right-handed flow), male 
gender, elevated systolic blood pressure, smoking, presence of valvular and ventricular dys-
functions, aortic dilatation, endocarditis, high total cholesterol levels, valve degeneration 
score, and genetic predisposition [45, 69]. Aneurysm formation, aortic dissection, severe val-
vular dysfunction, and endocarditis are the most important causes of morbidity and mortality 
of BAV disease. AR is the most common complication in younger patients, more common in 
males, whereas AS is more common in elderly and females [45, 55]. In addition, RN BAV phe-
notype is strongly predictive of valve intervention when compared with RL BAV phenotype. 
RN BAV phenotype has a fourfold risk of time-related valve intervention compared with RL 
BAV phenotype during childhood [39, 66].
Some BAV cases may present with severe stenosis or regurgitation especially in infants or 
children. Children who present with AS in infancy have more severe disease and poor out-
comes. Fortunately, balloon valvuloplasty is the successful treatment of choice for severe AS 
in this age group because of very little calcification [70].
With respect to the BAV manifestations, it is estimated that only 1 in 50 children would have 
a clinically significant valve disease by adolescence. The majorities of BAV patients have rela-
tively normal valve function and remain undiagnosed until 40 years of age, when stenosis 
develops because of leaflet calcification. In total, 53% of the BAV patients with isolated AS 
undergo valve replacement [65, 70, 71]. In the elderly population, AS is the most common 
presentation which causes 75% of patients to undergo surgery, while AR was the reason for 
intervention in only 13–16% of BAV patients [45, 72]. Asymptomatic adults without signifi-
cant valve dysfunction enjoy excellent long-term survival with a 10- and 20-year survival rate 
of 97 and 90%, respectively, identical to the expected survival of the population matched for 
age and sex [73]. Mean follow-up of 15 years showed a 6.7% death ratio, 1.4% of which were 
related with the aortic valve endocarditis, 0.47% with AS, and 0.47% with AR. In total, 18.3% 
of these patients underwent aortic valve surgery, most of which were due to severe AS [73]. 
The 10-year survival rate of the asymptomatic young adults with BAV was found to be 96%. 
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Aortic valve and ascending aorta surgery were performed in 29% of these patients [46]. On 
the other hand, patients with BAV-AR and root aneurysm have shown a higher risk of aortic 
dissection and rupture [74].
Aortic dissection occurs 9 times more often and at an average of 1 decade earlier among 
patients with BAV than those with TAV [63]. The patients with BAV and aortic aneurysm 
>4.5 cm have been found eight times more likely to undergo an aortic dissection [75]. The 
patients with BAV-AR have a tenfold higher risk of post-AVR aortic dissection than the 
patients with BAV-AS [76]. The aortic dissection rate in BAVs has been found to be 0.77% and 
the frequency of aortic dissection is 0.1% per patient’s year of follow-up [45].
The aortic diameter at the baseline is also an important predictor of aortic dilatation. In chil-
dren under 18 years old, ascending aorta z score has been shown to progress with time and an 
initial z score > 2 with the presence of AS has been accepted as a clinical marker for higher z 
scores in early adulthood [48]. The z scores of 4 or above, present in 13% of the patients under 
18 years old, have been considered to reveal significant aortic dilation which predicts the sub-
sequent aneurysm development [75] Relevantly, it has been shown that an aortic diameter of 
4 cm or more at the baseline evaluation independently predicts the subsequent development 
of aneurysm. The incidence of aortic dissection in these patients during 16 years of follow-
up was 3.1%, significantly higher than the general population [75]. Dissection rates in the 
patients with the aortic diameters of above 3.5, 4.5, and 5.5 cm are 8.5, 57.1, and 10%, respec-
tively [77]. The aortic size larger than 4.5 cm or aortic cross-sectional area/height > 8–10 should 
be considered for concurrent aortic valve and ascending aorta surgery [78, 79].
BAV types can predict the progression of aortic valve dysfunction or the development of aortic 
aneurysms [80]. The presence of a raphe has been associated with a higher prevalence of signif-
icant AS and AR, which increase the need for surgery. Despite the higher mortality in patients 
with BAV and raphe, raphe is not independently associated with increased all-cause mortality.
7. Treatment strategies
7.1. Medical treatment
Beta-adrenergic blockers, angiotensin converting enzyme inhibitors, and angiotensin recep-
tor blockers are the antihypertensive agents of choice. Beta-adrenergic blockers have the theo-
retical advantage of reducing aortic wall shear stress, whereas angiotensin receptor blockers 
have been shown to reduce the rate of aortic growth in patients with Marfan’s syndrome [24]. 
The studies about the various treatment modalities are continuing vigorously.
7.2. Intervention
During childhood, insertion of a prosthetic valve is suboptimal because of the continuing 
growth of the child. Fortunately, at this stage, the aortic valve is usually not calcified and 
valvuloplasty can successfully disrupt the commissural fusion and relieve obstruction. 
Valvuloplasty is the interventional strategy of choice in children and in some young adults 
with BAV and AS [70].
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7.3. Surgical treatment
Patients who have an aortic root or ascending aorta with a diameter of 45–50 mm may be 
considered for surgery only if they have high-risk features such as a family history of aortic 
dissection, rupture, or sudden death, and an aortic growth rate of more than 5 mm per year 
and if there is no need for valvular surgery [81]. Currently, aortic root surgery is not usually 
performed if the root measurement is <45 mm, or ratio of maximum ascending aorta area to 
body-height ratio is <10 cm2/m [82]. Guidelines recommend ascending aortic replacement in 
patients with BAV if the ascending aortic diameter is ≥50 mm. Concomitant aortic surgery is 
suggested if the diameter exceeds 45 mm [83]. Nonetheless, some authors have recommended 
ascending aorta surgery at 40 mm along with concomitant aortic valve regurgitataion (AVR), 
if the operation risk is low and expected survival is 1 decade or longer. Moreover, many sur-
geons consider reinforcing or replacing the ascending aorta at the time of valve surgery if there 
is an increased risk of further root dilation [84–86]. Aortic root dilatation may progress after 
AVR in the patients with pure AR. BAV patients with AR and root dilatation of 40–50 mm (root 
phenotype) are associated with significant risk (34%) of post-AVR aortic events. Therefore, 
simultaneous aortic root surgery is suggested in the patients with BAV-AR and aortic root 
diameter > 40 mm during their initial AVR procedure [86]. Some of the surgeons recommend 
aortic repair at the time of BAV surgery if either the aortic diameter exceeds approximately 
45 mm or the aortic cross-sectional area/height is above 8–9 cm2/m or z score is above 7 [82].
8. Conclusion
BAV is a very common, congenital, phenotypically variable, and genetically heteroge-
neous heart disease. It has a complex developmental process and distinct morphological 
phenotypes. The clinical course is highly non-predictable. Children with BAV are mostly 
asymptomatic. However, the cases with severe AS may be encountered early in life and 
need intervention. Aortic dilatation and valvular dysfunction may begin in infancy and 
make progress with age. The factors determining the prognosis of BAV disease are older 
age, RN or RL BAV phenotype, flow dynamics (right-handed flow), male gender, elevated 
systolic blood pressure, smoking, presence of valvular and ventricular dysfunctions, aortic 
dilatation, endocarditis, high total cholesterol levels, valve degeneration score, and genetic 
predisposition. Surgery is recommended for the patients with severe valvular dysfunction 
(AS, AR), aortic dilatation, or aneurysm.
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